Life Sciences Tools and Services
Company Overview of Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. discovers and exploits small molecule drugs to act at novel therapeutic targets in cancer and cardiovascular diseases. Prolexys Pharmaceuticals, Inc. was formerly known as Myriad Proteomics, Inc. and changed its name to Prolexys Pharmaceuticals, Inc. in September 2003. Prolexys Pharmaceuticals, Inc. was founded in 2001 and is based in Salt Lake City, Utah.
2150 West Dauntless Avenue (1000 North)
Salt Lake City, UT 84116
Founded in 2001
Key Executives for Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Prolexys Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.